Pay in 4 interest-free payments of $6.58 Learn more
Ships within 48 hours · Estimated delivery Sep 22 - Sep 27
Inflammation may help explain how GLP-1 drugs prevent AFib New research presented at Heart Rhythm 2026 suggests taking GLP-1 receptor agonists (GLP-1-RAs) may reduce the risk of atrial fibrillation (AFib) and improve survival through mechanisms that extend beyond weight loss alone
To lose 15 per cent of the body weight in two years is phenomenal
They are not assessed by the MHRA for efficacy, only for safety
Its generally best to avoid overeating, heavy alcohol use, and very high-fat meals early in treatment, as these may worsen gastrointestinal side effects
What does the GIP pathway do that GLP-1 doesn't
US$ 28.68
US$ 27.60
US$ 24.83
US$ 28.80
US$ 20.38
US$ 22.92
US$ 22.92
US$ 27.28
